BR112020010343A2 - método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico - Google Patents

método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico Download PDF

Info

Publication number
BR112020010343A2
BR112020010343A2 BR112020010343-8A BR112020010343A BR112020010343A2 BR 112020010343 A2 BR112020010343 A2 BR 112020010343A2 BR 112020010343 A BR112020010343 A BR 112020010343A BR 112020010343 A2 BR112020010343 A2 BR 112020010343A2
Authority
BR
Brazil
Prior art keywords
inositol
myo
chiro
composition
weight ratio
Prior art date
Application number
BR112020010343-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Mónica Olivares Martín
Juristo Fonollá Joyá
María Paz Díaz-Ropero Medina
José Luis López Larramendi
Nicolás Mendoza Ladrón De Guevara
Original Assignee
Biosearch, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosearch, S.A. filed Critical Biosearch, S.A.
Publication of BR112020010343A2 publication Critical patent/BR112020010343A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
BR112020010343-8A 2017-11-23 2018-04-19 método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico BR112020010343A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382791 2017-11-23
EP17382791.6 2017-11-23
PCT/EP2018/060077 WO2019101368A1 (en) 2017-11-23 2018-04-19 Method for increasing embryo implantation rate in a female subject suffering polycystic ovary syndrome

Publications (1)

Publication Number Publication Date
BR112020010343A2 true BR112020010343A2 (pt) 2020-11-10

Family

ID=60569854

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112020010343-8A BR112020010343A2 (pt) 2017-11-23 2018-04-19 método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico

Country Status (12)

Country Link
US (1) US11484540B2 (https=)
EP (1) EP3713552A1 (https=)
JP (1) JP7257399B2 (https=)
CN (1) CN111655245B (https=)
AU (1) AU2018373174B2 (https=)
BR (1) BR112020010343A2 (https=)
CA (1) CA3083301C (https=)
MA (1) MA50784A (https=)
MX (1) MX2020005223A (https=)
NZ (1) NZ765637A (https=)
TW (1) TWI842684B (https=)
WO (1) WO2019101368A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2749783C1 (ru) * 2020-12-11 2021-06-16 Федеральное государственное автономное образовательное учреждение высшего образования "Российский национальный исследовательский медицинский университет имени Н.И. Пирогова" Министерства здравоохранения Российской Федерации (ФГАОУ ВО РНИМУ им. Н.И. Пирогова Минздрава России) Способ лечения синдрома поликистозных яичников, ассоциированного с метаболическим синдромом
CN114159402A (zh) * 2021-12-21 2022-03-11 湖州展望天明药业有限公司 一种不透明植物胶囊及其制备方法
EP4620480A1 (en) 2022-11-16 2025-09-24 Kansai Medical University Educational Corporation Implantation facilitator, and screening system therefor
CN117017929B (zh) * 2023-09-11 2024-11-08 山东奥克斯畜牧种业有限公司 一种用于提高采卵效果的组合物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2047686C (en) 1989-03-08 2000-09-05 Joseph Larner Dietary supplement for insulin-resistant diabetics
US5563059A (en) 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
US5906979A (en) * 1998-01-27 1999-05-25 Insmed Pharmaceuticals, Inc. Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility
US7105489B2 (en) * 2002-01-22 2006-09-12 Amylin Pharmaceuticals, Inc. Methods and compositions for treating polycystic ovary syndrome
JP2006213684A (ja) 2005-02-07 2006-08-17 Hokko Chem Ind Co Ltd インスリン抵抗性改善に用いられる組成物及び健康用食品
ITRM20070341A1 (it) * 2007-06-20 2008-12-21 Lo Li Pharma Srl Formulazione integrativa inofolic finalizzata al controllo dell'induzione dell'ovulazione in programmi di procreazione medicalmente assistita
EP2596132A4 (en) 2010-07-23 2013-12-18 Harvard College METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS
ITMI20110445A1 (it) * 2011-03-22 2012-09-23 Lo Li Pharma Srl Formulazione farmaceutica comprendente inositolo.
ITFI20110252A1 (it) * 2011-11-22 2013-05-23 Lo Li Pharma Srl Composizione farmaceutica comprendente myo-inositolo e d-chiro-inositolo.
ITRM20130655A1 (it) * 2013-11-26 2015-05-27 Dicofarm Spa Prodotto a base di una associazione di glucomannano ed inositolo
US9259410B2 (en) 2014-04-08 2016-02-16 Oculus Innovative Sciences, Inc. Methods of treating polycystic ovarian syndrome using chlorogenic acid and inositol
IN2014MU01312A (https=) 2014-04-09 2015-10-16 Olive Healthcare
ITUA20162575A1 (it) 2016-04-13 2017-10-13 S&R Farm S P A Composizione farmaceutica o nutraceutica per l’uso nel trattamento della sindrome dell’ovaio policistico o di malattie o disturbi correlati ad essa
ITUA20163025A1 (it) * 2016-04-29 2017-10-29 Sochim Int S P A Composizione per il trattamento della sindrome dell’ovaio policistico

Also Published As

Publication number Publication date
JP7257399B2 (ja) 2023-04-13
MX2020005223A (es) 2020-10-19
EP3713552A1 (en) 2020-09-30
MA50784A (fr) 2020-09-30
NZ765637A (en) 2025-11-28
TWI842684B (zh) 2024-05-21
CN111655245A (zh) 2020-09-11
CA3083301A1 (en) 2019-05-31
US11484540B2 (en) 2022-11-01
JP2021504360A (ja) 2021-02-15
RU2020120655A3 (https=) 2021-12-23
TW201924692A (zh) 2019-07-01
AU2018373174A1 (en) 2020-07-09
US20200330495A1 (en) 2020-10-22
CA3083301C (en) 2024-05-21
WO2019101368A1 (en) 2019-05-31
CN111655245B (zh) 2023-08-08
RU2020120655A (ru) 2021-12-23
AU2018373174B2 (en) 2024-07-25

Similar Documents

Publication Publication Date Title
AU2014359649B2 (en) Composition useful for promoting female fertility
BR112020010343A2 (pt) método para aumentar taxa de implantação de embrião em um paciente feminino sofrendo de síndrome de ovário policístico
CN103462896A (zh) 诱导癌细胞凋亡的方法和应用
AU2017206480A1 (en) Composition, containing Loganin or a derivative thereof as an active ingredient for preventing, remedying, or treating female climacteric syndrome
RU2790696C2 (ru) Способ повышения частоты имплантации эмбриона у субъекта женского пола, страдающего синдромом поликистозных яичников
RU2406489C1 (ru) Способ профилактики гестоза и его осложнений у свиноматок
AU2019257990B2 (en) Compositions for treating female sexual dysfunction
US20150031775A1 (en) Composition and method for affecting male and female hormone levels
EP2253228B1 (en) Composition for controlling and improving female and male gametogenesis
RS65682B1 (sr) Tretman fibroida vitaminom d i agensom kao što je epigalokatehin galat (egcg)
US9339458B2 (en) Use of vaginal insulin sensitizing agents
RU2846245C2 (ru) Применение алкалоидов, содержащихся в веточках шелковицы, для получения лекарственного средства для лечения синдрома поликистозных яичников
CN109331022B (zh) 提高女性卵巢功能改善女性皮肤的组合物和制备工艺
US11058737B2 (en) Use of Euycoma longifolia extract in alleviating symptoms and/or conditions associated with hormonal imbalance in females
HK40111827B (zh) 一种用於卵巢保健的组合物及其制备方法和应用
CN120731080A (zh) 用于治疗多囊卵巢综合征的组合物
HK40111827A (zh) 一种用於卵巢保健的组合物及其制备方法和应用
HK40127583A (zh) 用於治疗多囊卵巢综合征的组合物
IT202300004827A1 (it) Composizione per uso nel trattamento della sindrome dell’ovaio policistico
IT202300002769A1 (it) Composizione per uso nel trattamento della sindrome dell’ovaio policistico
UA145549U (uk) Спосіб лікування доброякісних пухлин яєчників у жінок під час вагітності
US20120004271A1 (en) Use of vaginally-administered insulin sensitizing agents
NZ719680B2 (en) Composition useful for promoting female fertility

Legal Events

Date Code Title Description
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]